Nephro-Urology Monthly

Published by: Kowsar

Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats

Bahar Rostami 1 , Mehdi Nematbakhsh 1 , 2 , 3 , * , Zahra Pezeshki 1 , Ardeshir Talebi 1 , 4 , Mohammad Reza Sharifi 2 , Fatemeh Moslemi 1 , Fatemeh Eshraghi-Jazi 1 and Farzaneh Ashrafi 1
Authors Information
1 Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Department of Physiology, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Institute of Basic and Applied Sciences Research, Isfahan, IR Iran
4 Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2014, 6 (5); e21546
  • Published Online: September 5, 2014
  • Article Type: Research Article
  • Received: June 28, 2014
  • Revised: July 7, 2014
  • Accepted: July 10, 2014
  • DOI: 10.5812/numonthly.21546

To Cite: Rostami B, Nematbakhsh M, Pezeshki Z, Talebi A, Sharifi M R, et al. Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats, Nephro-Urol Mon. 2014 ; 6(5):e21546. doi: 10.5812/numonthly.21546.

Abstract
Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23(5): 460-4[PubMed]
  • 2. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2010; 2(11): 2490-518[DOI][PubMed]
  • 3. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001; 12(12): 2683-90[PubMed]
  • 4. Luke DR, Vadiei K, Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant. 1992; 7(1): 1-7[PubMed]
  • 5. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002; 110(6): 835-42[DOI][PubMed]
  • 6. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985; 249(4 Pt 2)-6[PubMed]
  • 7. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997; 71(11): 677-83[PubMed]
  • 8. Bagnis C, Beaufils H, Jacquiaud C, Adabra Y, Jouanneau C, Le Nahour G, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant. 2001; 16(5): 932-8[PubMed]
  • 9. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, Talebi A, Haghighi M, Pezeshki Z, et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci. 2011; 16(11): 1389-96[PubMed]
  • 10. Mohamed HE, El-Swefy SE, Mohamed RH, Ghanim AM. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. Exp Toxicol Pathol. 2013; 65(1-2): 197-203[DOI][PubMed]
  • 11. Saleh S, Ain-Shoka AA, El-Demerdash E, Khalef MM. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury. Chemotherapy. 2009; 55(6): 399-406[DOI][PubMed]
  • 12. Nematbakhsh M, Ashrafi F, Safari T, Talebi A, Nasri H, Mortazavi M, et al. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats. J Nephrol. 2012; 25(3): 410-7[DOI][PubMed]
  • 13. Soltani N, Nematbakhsh M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats. Nephrourol Mon. 2013; 5(4): 884-90[DOI][PubMed]
  • 14. Saadat A, Shariat Maghani SS, Rostami Z, Davoudi A, Davoudi F, Shafie A, et al. Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity. Ren Fail. 2014; 36(1): 5-8[DOI][PubMed]
  • 15. Nematbakhsh M , Talebi A , Nasri H , Safari T , et al . Some evidence for sex-based differences in cisplatin-induced nephrotoxicity in rats. Clin Exp Med Lett. 2012; 53(1-2): 29-32
  • 16. Nematbakhsh M, Ebrahimian S, Tooyserkani M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female. Nephrourol Mon. 2013; 5(3): 818-21[DOI][PubMed]
  • 17. Pezeshki Z, Nematbakhsh M, Nasri H, Talebi A, Pilehvarian AA, Safari T, et al. Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int. 2013; 20(1): 43-7[DOI][PubMed]
  • 18. Lu Y, Fu Y, Ge Y, Juncos LA, Reckelhoff JF, Liu R. The vasodilatory effect of testosterone on renal afferent arterioles. Gend Med. 2012; 9(2): 103-11[DOI][PubMed]
  • 19. Kim J, Kil IS, Seok YM, Yang ES, Kim DK, Lim DG, et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem. 2006; 281(29): 20349-56[DOI][PubMed]
  • 20. Soljancic A, Ruiz AL, Chandrashekar K, Maranon R, Liu R, Reckelhoff JF, et al. Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury. Am J Physiol Regul Integr Comp Physiol. 2013; 304(11)-8[DOI][PubMed]
  • 21. Ammer U, Natochin Y, David C, Rumrich G, Ullrich KJ. Cisplatin nephrotoxicity: site of functional disturbance and correlation to loss of body weight. Ren Physiol Biochem. 1993; 16(3): 131-45[PubMed]
  • 22. Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res. 2000; 41(4): 405-11[DOI][PubMed]
  • 23. Deegan PM, Nolan C, Ryan MP, Basinger MA, Jones MM, Hande KR. The role of the renin-angiotensin system in cisplatin nephrotoxicity. Ren Fail. 1995; 17(6): 665-74[PubMed]
  • 24. Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 2002; 48(6): 309-15[PubMed]
  • 25. Saleh S, El-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005; 97(2): 91-7[DOI][PubMed]
  • 26. Stakisaitis D, Dudeniene G, Jankunas RJ, Grazeliene G, Didziapetriene J, Pundziene B. Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas). 2010; 46(1): 45-50[PubMed]
  • 27. Pezeshki Z, Nematbakhsh M, Mazaheri S, Eshraghi-Jazi F, Talebi A, Nasri H, et al. Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. ISRN Oncol. 2012; 2012: 890310[DOI][PubMed]
  • 28. Nematbakhsh M, Pezeshki Z, Eshraghi-Jazi F, Ashrafi F, Nasri H, Talebi A, et al. Vitamin E, Vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model. Int J Nephrol 2012; 2012: 284896
  • 29. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol. 2006; 44(8): 1173-83[DOI][PubMed]
  • 30. Maheshwari RA, Sailor GU, Patel L, Balaraman R. Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol. 2013; 45(4): 354-8[DOI][PubMed]
  • 31. Maines MD, Sluss PM, Iscan M. cis-platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis. Endocrinology. 1990; 126(5): 2398-406[DOI][PubMed]
  • 32. Allan CA, McLachlan RI. Androgens and obesity. Curr Opin Endocrinol Diabetes Obes. 2010; 17(3): 224-32[DOI][PubMed]
  • 33. Iglesias P, Carrero JJ, Diez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol. 2012; 25(1): 31-42[DOI][PubMed]
  • 34. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH, Channer KS. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010; 96(22): 1821-5[DOI][PubMed]
  • 35. Rao SR, Kini S, Tamler R. Sex hormones and bariatric surgery in men. Gend Med. 2011; 8(5): 300-11[DOI][PubMed]
  • 36. Saad F. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? Diabetes Metab Res Rev. 2012; 28 Suppl 2: 52-9[DOI][PubMed]
  • 37. Kyriazis J, Tzanakis I, Stylianou K, Katsipi I, Moisiadis D, Papadaki A, et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant. 2011; 26(9): 2971-7[DOI][PubMed]
  • 38. Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, et al. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6(7): 1617-25[DOI][PubMed]
  • 39. Carrero JJ, Barany P, Yilmaz MI, Qureshi AR, Sonmez A, Heimburger O, et al. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. Nephrol Dial Transplant. 2012; 27(2): 709-15[DOI][PubMed]
  • 40. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem. 2004; 279(50): 52282-92[DOI][PubMed]
  • 41. Verzola D, Gandolfo MT, Salvatore F, Villaggio B, Gianiorio F, Traverso P, et al. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int. 2004; 65(4): 1252-61[DOI][PubMed]
  • 42. Sadowska-Krepa E, Klapcinska B, Jagsz S, Sobczak A, Chrapusta SJ, Chalimoniuk M, et al. High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats. Cardiovasc Toxicol. 2011; 11(2): 118-27[DOI][PubMed]
  • 43. Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013; 21(10): 1975-81[DOI][PubMed]
  • 44. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 1993; 45(6): 509-11[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments